Navigation Links
Cord Blood America Highlights Significant 2009 Progress

SANTA MONICA, Calif. and LAS VEGAS, July 20 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), one of the largest umbilical cord blood stem cell preservation companies ( ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, today said its accomplishments in the first half of 2009 are the most significant in the Company's history and Cord Blood America is progressing to its goal of being the most important company in stem cell storage in the world.

  • January 6 - Launched the first social media campaign in the industry to start a public conversation about the potential usefulness of stem cells and the importance of storing umbilical cord blood stem cells.
  • January 9 - Established its three pillars of success for 2009: Organic growth, acquisitions and debt reduction leading to a healthy balance sheet.
  • February 9 - The Obama Administration announces its plan and support of stem cell research in the United States; Cord Blood America is listed on the ETF Innovators Stem Cell 40 company index.
  • February 12 - CBAI announces $1 million reduction in long term debt.
  • February 25 - CBAI announces restructuring of long term debt to free up cash flow for the company.
  • March 5 - CBAI noted as the top stock performer on ETF Innovators Stem Cell index, with a year-to-date stock price increase of 279 percent.
  • April 5 - Congress introduces legislation to promote Family Banking of Umbilical Cord Blood stem cells; CBAI announces its total long term debt reduction at $1.75 million.
  • April 9 - CBAI announces its first customer in Germany, noting its dedication to organic growth.
  • April 23 - CBAI announces additional debt reduction of $817,000.
  • May 7 - CBAI says it will acquire or build its own stem cell processing and storage laboratory, eliminating the need to outsource lab services and projecting a significant increase in gross profit once complete.
  • May 14 - CBAI announces it received a $2.3 million commitment to finance the building of its stem cell lab.
  • May 27 - CBAI announces debt has been reduced by $4.194 million in 2009.
  • June 11- CBAI announces additional expansion in Europe.
  • June 22 - CBAI announces contracting independent affiliate to sell services in Caribbean and Central America.

Since the end of the mid-point of 2009, Cord Blood America has further secured $7.5 million in long term equity financing for growth and acquisition opportunities; announced it has begun building the one of the largest stem cell labs in the U.S.; and announced hiring of an experienced, successful management team to manage its new laboratory

"On January 6, 2009, the closing CBAI stock price was $0.0017. On July 10, 2009, the closing stock price was 0.0033, a 94% increase in 6 months of trading. That's not where we want to be, we are still very undervalued, and I understand that the day-to-day swings of our very liquid and volatile stock price cause some investor concern," said Matthew Schissler, Chairman and CEO. "I tell investors to take a snapshot of the last six months, not six hours. Micro cap stocks are perhaps not for the faint of heart. We believe we're building a very valuable company and this snapshot of the past six months shows our progress."

"In January, CBAI stated its mission is to lay the foundation for a much stronger healthier company by the end of 2009, which included organic growth, acquisition and debt reduction. As you can see by these highlights, we remain laser-focused on executing these strategies," Mr. Schissler said. "Because of our focus, we were able to raise significant funding to build a lab with the future growth opportunities it affords us. We are also pleased by the current support of stem cell research in Washington, D.C. and Congressional and state legislative focus on family stem cell banking legislation."

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at For investor information, visit

Forward-Looking Statements

Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as ``anticipate,'' ``believe,'' ``expect,'' ``future,'' ``intend,'' ``plan,'' and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company's performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

        Paul Knopick
        E & E Communications

SOURCE Cord Blood America, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Blood Test Shows Statistically Significant Association With Alzheimers Disease (AD), May Predict Conversion of Mild Cognitive Impairment to AD
2. Dr. David Williams Featured on
3. Life-Saving Thermal Angel Blood Warmer Is Immediately Available For Use By U.S. Troops In Harms Way
4. Leading Blood Centers, LifeSource and Central Blood Bank, Spotlight a Unique Donor Population During National Hereditary Hemochromatosis Awareness Month
5. Blood Rush to the Brain When Angry Is a Good Sign
6. Cord Blood America Hires Management Team for Its New Stem Cell Laboratory
7. Blood vessel bends and branches put the brakes on statins
8. Pioneer of Digital Place-Based Media Joins World's Leading Blood Pressure and Health Kiosk Manufacturer
9. Cord Blood America Leases Las Vegas Building for Its Own Stem Cell Laboratory
10. Vegetable Amino Acid Lowers Blood Pressure
11. Intensive management can improve blood pressure in non-adherent hypertensive patients
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in ... ways they remain in the eye of the beholder, according to experts who offered ... The American Journal of Managed Care. For the full issue, click here . ...
(Date:6/26/2016)... ... 2016 , ... PawPaws brand pet supplements owned by Whole Health ... the health of felines. The formula is all-natural and is made from Chinese herbs ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize each ... Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into hand ... select a ProHand generator and drag it above media or text in the Final ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/24/2016)... CHAPEL HILL, N.C. , June 24, 2016 ... in healthcare decisions and regulators/payers have placed more ... this new environment, patient support programs in the ... support for patients, medications. Consequently, pharmaceutical companies are ... to ensure they are providing products and services ...
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
Breaking Medicine Technology: